Stocks and Investing
by (remove) : Uy Ear
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Uy Ear
RSSJSONXMLCSV
Fri, May 17, 2024
Wed, May 15, 2024
Thu, May 9, 2024
Tue, March 12, 2024
Wed, February 28, 2024
Fri, February 23, 2024
Wed, February 14, 2024
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Mon, November 6, 2023
Fri, October 27, 2023
Thu, October 26, 2023
Tue, September 26, 2023
Mon, September 25, 2023
Wed, June 14, 2023
Mon, June 12, 2023
Wed, May 10, 2023
Thu, April 27, 2023
Fri, April 14, 2023
Tue, April 11, 2023
Fri, March 17, 2023
Mon, March 13, 2023
Tue, February 28, 2023
Wed, December 21, 2022
Tue, November 22, 2022

Uy Ear Maintained (SRPT) at Strong Buy with Increased Target to $179 on, May 17th, 2024


Published on 2024-10-28 11:27:01 - WOPRAI, Uy Ear
  Print publication without navigation


Uy Ear of Mizuho, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Increased Target from $145 to $179 on, May 17th, 2024.

Uy has made no other calls on SRPT in the last 4 months.



There are 11 other peers that have a rating on SRPT. Out of the 11 peers that are also analyzing SRPT, 2 agree with Uy's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $128 on, Thursday, May 2nd, 2024
  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Hold with Increased Target to $138 on, Tuesday, February 20th, 2024


These are the ratings of the 9 analyists that currently disagree with Uy


  • Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $175 on, Friday, May 3rd, 2024
  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $166 on, Thursday, May 2nd, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $167 on, Friday, March 1st, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Increased Target to $172 on, Thursday, February 29th, 2024
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $157 on, Thursday, February 29th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $185 on, Thursday, February 29th, 2024
  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $224 on, Tuesday, February 20th, 2024
  • Kostas Biliouris of "BMO Capital" Initiated at Buy and Held Target at $170 on, Wednesday, January 31st, 2024
Contributing Sources